Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity

Journal of Experimental Medicine

Volumn 188, Issue 11, 1998, Pages 2067-2074

  Imada, Kazunori ^a   Bloom, Eda T ^b   Nakajima, Hiroshi ^a   Horvath Arcidiacono, Judith A ^b   Udy, Garry B ^c   Davey, Helen W ^d   Leonard, Warren J ^a,e  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c Ministry for Primary Industries   (New Zealand)

^d RUAKURA RESEARCH CENTRE   (New Zealand)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Interleukin 15; Interleukin 2; Natural killer cells; Stat5a; Stat5b

Indexed keywords

CD3 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; STAT5 PROTEIN; STAT5B PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLYSIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL;

ANIMALS; CELL DIVISION; CYTOTOXICITY, IMMUNOLOGIC; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MILK PROTEINS; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0031774896     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.11.2067     Document Type: Article

References (49)

1. Ihle, J.N. 1996. STATs: signal transducers and activators of transcription. Cell. 84:331-334.
2. Horvath, C.M. and J.E. Darnell, Jr. 1997. The state of STATs: recent developments in the study of signal transduction to the nucleus. Curr. Opin. Cell Biol. 9:233-239.
3. Leonard, W.J. and J.J. O'Shea. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16:293-322.
4. Durbin, J.E., R. Hackenmiller, M.C. Simon, and D.E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 84:443-450.
5. Meraz, M.A., J.M. White, K.C. Sheehan, E.A. Bach, S.J. Rodig, A.S. Dighe, D.H. Kaplan, J.K. Riley, A.C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 84:431-442.
6. Thierfelder, W.E., J.M. van Deursen, K. Yamamoto, R.A. Tripp, S.R. Sarawar, R.T. Carson, M.Y. Sangster, D.A. Vignali, P.C. Doherty, G.C. Grosveld, and J.N. Ihle. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 382:171-174.
7. Kaplan, M.H., Y.L. Sun, T. Hoey, and M.J. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 382:174-177.
8. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature. 380:627-630.
9. Shimoda, K., J. van Deursen, M.Y. Sangster, S.R. Sarawar, R.T. Carson, R.A. Tripp, C. Chu, F.W. Quelle, T. Nosaka, D.A. Vignali, et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature. 380:630-633.
10. Kaplan, M.H., U. Schindler, S.T. Smiley, and M.J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity. 4:313-319.
11. Takeda, K., K. Noguchi, W. Shi, T. Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto, and S. Akira. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA. 94:3801-3804.
12. Wakao, H., F. Gouilleux, and B. Groner. 1994. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO (Eur. Mol. Biol. Organ.) J. 13:2182-2191.
13. Mui, A.L., H. Wakao, A.M. O'Farrell, N. Harada, and A. Miyajima. 1995. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologues. EMBO (Eur. Mol. Biol. Organ.) J. 14:1166-1175.
14. Azam, M., H. Erdjument-Bromage, B.L. Kreider, M. Xia, F. Quelle, R. Basu, C. Saris, P. Tempst, J.N. Ihle, and C. Schindler. 1995. Interleukin-3 signals through multiple isoforms of Stat5. EMBO (Eur. Mol. Biol. Organ.) J. 14:1402-1411.
15. Hou, J., U. Schindler, W.J. Henzel, S.C. Wong, and S.L. McKnight. 1995. Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity. 2:321-329.
16. Liu, X., G.W. Robinson, F. Gouilleux, B. Groner, and L. Hennighausen. 1995. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl. Acad. Sci. USA. 92:8831-8835.
17. Lin, J.-X., J. Mietz, W.S. Modi, S. John, and W.J. Leonard. 1996. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J. Biol. Chem. 271:10738-10744.
18. Copeland, N.G., D.J. Gilbert, C. Schindler, Z. Zhong, Z. Wen, J.E. Darnell, Jr., A.L. Mui, A. Miyajima, F.W. Quelle, J.N. Ihle, and N.A. Jenkins. 1995. Distribution of the mammalian Stat gene family in mouse chromosomes. Genomics. 29:225-228.
19. Moriggl, R., V. Gouilleux-Gruart, R. Jahne, S. Berchtold, C. Gartmann, X. Liu, L. Hennighausen, A. Sotiropoulos, B. Groner, and F. Gouilleux. 1996. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol. Cell. Biol. 16:5691-5700.
20. Liu, X., G.W. Robinson, K.-U. Wagner, L. Garrett, A. Wynshaw-Boris, and L. Hennighausen. 1997. Stat5a is mandatory for adult mammary gland development and lactogenesis. Gen. Dev. 11:179-186.
21. Udy, G.B., R.P. Towers, R.G. Snell, R.J. Wilkins, S.-H. Park, P.A. Ram, D.J. Waxman, and H.W. Davey. 1997. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA. 94:7239-7244.
22. Teglund, S., C. McKay, E. Schuetz, J.M. van Deursen, D. Stravopodis, D. Wang, M. Brown, S. Bodner, G. Grosveld, and J.N. Ihle. 1998. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 93:841-850.
23. Feldman, G.M., L.A. Rosenthal, X. Liu, M.P. Hayes, A. Wynshaw-Boris, W.J. Leonard, L. Hennighausen, and D.S. Finbloom. 1997. STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood. 90:1768-1776.
24. Nakajima, H., X.W. Liu, A. Wynshaw-Boris, L.A. Rosenthal, K. Imada, D.S. Finbloom, L. Hennighausen, and W.J. Leonard. 1997. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction. Immunity. 7:691-701.
25. Kaczmarek, L., B. Calabretta, H.-T. Kao, N. Heintz, J. Nevins, and R. Baserga. 1987. Control of hsp70 RNA levels in human lymphocytes. J. Cell Biol. 104:183-187.
26. Shinkai, Y., K. Takio, and K. Okumura. 1988. Homology of perform to the ninth component of complement (C9). Nature. 334:525-527.
27. Bloom, E.T., and E.L. Korn. 1983. Quantification of natural cytotoxicity by humans lymphocyte subpopulations isolated by density: heterogeneity of the effect cells. J. Immunol. Methods. 58:323-335.
28. Lin, J.X., and W.J. Leonard. 1997. Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev. 8:313-332.
29. Sperisen, P., S.M. Wang, E. Soldaini, M. Pla, C. Rusterholz, P. Bucher, P. Corthesy, P. Reichenbach, and M. Nabholz. 1995. Mouse interleukin-2 receptor α gene expression: interleukin-1 and interleukin-2 control transcription via distinct cis-acting elements. J. Biol. Chem. 270:10743-10753.
30. John, S., C.M. Robbins, and W.J. Leonard. 1996. An IL-2 response element in the human IL-2 receptor α chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO (Eur. Mol. Biol. Organ.) J. 15:5627-5635.
31. Lecine, P., M. Algarte, P. Rameil, C. Beadling, P. Bucher, M. Nabholz, and J. Imbert. 1996. Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor α gene. Mol. Cell. Biol. 16:6829-6840.
32. Kundig, T.M., H. Schorle, M.F. Bachmann, H. Hengartner, R.M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science. 262:1059-1061.
33. Giri, J.G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L.S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO (Eur. Mol. Biol. Organ.) J. 13:2822-2830.
34. Bamford, R.N., A.J. Grant, J.D. Burton, C. Peters, G. Kurys, C.K. Goldman, J. Brennan, E. Roessler, and T.A. Waldmann. 1994. The interleukin (IL)-2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T cell proliferation and the induction of lymphokine activated killer cells. Proc. Natl. Acad. Sci. USA. 92: 4940-4944.
35. Helander, T.S., O. Carpén, O. Turunen, P.E. Kovanen, A. Vaheri, and T. Timonen. 1996. ICAM-2 redistributed by ezrin as a target for killer cells. Nature. 382:265-268.
36. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K.J. Olsen, E.R. Podack, R.M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:31-37.
37. Suzuki, H., G.S. Duncan, H. Takimoto, and T.W. Mak. 1997. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor β chain. J. Exp. Med. 185:499-505.
38. DiSanto, J.P., W. Müller, D. Guy-Grand, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin-2 receptor γ chain. Proc. Natl. Acad. Sci. USA. 92:377-381.
39. Cao, X., E.W. Shores, J. Hu-Li, M.R. Anver, B.L. Kelsall, S.M. Russell, J. Drago, M. Noguchi, A. Grinberg, E.T. Bloom, et al. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity. 2:223-238.
40. Nosaka T., J.M. van Deursen, R.A. Tripp, W.E. Thierfelder, B.A. Witthuhn, A.P. McMickle, P.C. Doherty, G.C. Grosveld and J.N. Ihle. 1995. Defective lymphoid development in mice lacking Jak3. Science. 270:800-802.
41. Thomis, D.C., C.B. Gurniak, E. Tivol, A.H. Sharpe, and L.J. Berg. 1995. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science. 270:794-797.
42. Park, S.Y., K. Saijo, T. Takahashi, M. Osawa, H. Arase, N. Hirayama, K. Miyake, H. Nakauchi, T. Shirasawa, and T. Saito. 1995. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity. 3:771-782.
43. Carson, W.E., J.G. Giri, M.J. Lindemann, M.L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M.A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395-1403.
44. Cavazzana-Calvo, M., S. Hacein-Bey, G. de Saint Basile, C. de Coene F. Selz, F. Le Deist, and A. Fischer. 1996. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from γc transduced severe combined immunodeficiency X1 bone marrow cells. Blood. 88:3901-3909.
45. Leclercq, G., V. Debacker, M. de Smedt, and J. Plum. 1996. Differential effects of interleukin-15 and interleukin-2 on the differentiation of bipotential T/natural killer progenitor cells. J. Exp. Med. 184:325-336.
46. Puzanov, I.J., M. Bennett, and V. Kumar. 1996. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J. Immunol. 157:4282-4285.
47. Ogasawara, K., S. Hida, N. Azimi, Y. Tagaya, T. Sato, T. Yokochi-Fukuda, T.A. Waldmann, T. Taniguchi, and S. Taki. 1998. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature. 391:700-703.
48. Lin, J.-X., N. Bhat, S. John, W.S. Queale, and W.J. Leonard. 1993. Characterization of the human interleukin-2 receptor β chain gene promoter: regulation of promoter activity by ets gene products. Mol. Cell. Biol. 13:6201-6210.
49. Lin, J.X., and W.J. Leonard. 1997. The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor β-chain promoter through non-canonical Egr and Sp1 binding sites. Mol. Cell. Biol. 17:3714-3722.